Dr. Anupama Deepa Kumar, MD

Dr. Kumar practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kumar's NPI, 1164879656, was assigned on May 16, 2016. Dr. Kumar graduated from Tufts University School Of Medicine in 2016. Dr. Kumar holds California license 277740.

Dr. Kumar's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kumar's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Kumar is also affiliated with Tufts Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kumar to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kumar is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kumar's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists multiple myeloma among the conditions Dr. Kumar treats.

CMS data shows 621 Medicare services from Dr. Kumar across 7 procedure codes in 2024, for 146 Medicare patients. Medicare paid $42,857 for them.

CMS counts 146 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 77 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 35% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 72, with 48% women.

In 2024, Dr. Kumar wrote 491 Medicare Part D claims for 58 patients. 67% of them were for generic drugs. CMS names the drug for 358 of them, across 14 drugs with 11 or more claims each, at $2,693,735 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links 4 papers to Dr. Kumar, published from 2020 to 2025. 2025 was the busiest year, with 2. Dr. Kumar's most frequent co-authors are Naomi Elizabeth Akagi, MD, Alfred Chung and Anil K. Gehi, MD.

CMS Open Payments shows 24 general payments to Dr. Kumar from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 92% of the total. Janssen Research & Development, LLC paid the most, $9,768.

Dr. Kumar graduated from Tufts University School Of Medicine in 2016.

Dr. Kumar is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.